Abudounaibi Abudoueryimu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Abudounaibi Abudoueryimu  – Kashi Prefecture Second People’s Hospital, China

Researcher Information
Affiliation Kashi Prefecture Second People’s Hospital
Country China
Scopus ID 60622239600
Documents 1
Subject Area Medicine
Event Scientific World Research Awards

The Best Researcher Award recognizes researchers who demonstrate scholarly excellence, scientific integrity, and meaningful contributions within their respective disciplines. Abudounaibi Abudoueryimu, affiliated with Kashi Prefecture Second People’s Hospital, has established an academic profile in the field of Medicine. The researcher’s documented scholarly output indexed by Scopus reflects participation in international scientific communication and contributes to the advancement of evidence-based medical research.[1]

Abstract

Abudounaibi Abudoueryimu is associated with Kashi Prefecture Second People’s Hospital and has an indexed research profile in Medicine. Recognition through the Best Researcher Award acknowledges scholarly activity, publication quality, and commitment to advancing clinical knowledge. Academic evaluation for such recognition commonly considers publication records, scientific relevance, ethical research practices, and contributions to healthcare improvement.[1]

Keywords

  • Medicine
  • Clinical Research
  • Scientific Publications
  • Healthcare
  • Evidence-Based Medicine
  • Scopus
  • Best Researcher Award

Introduction

Modern medical research integrates clinical practice, scientific investigation, and interdisciplinary collaboration to improve patient outcomes. Researchers working within hospital environments contribute to diagnostic innovation, therapeutic development, and healthcare quality through evidence-driven investigations. Scholarly recognition programs highlight researchers whose work demonstrates academic merit and professional commitment.[2]

Research Profile

Abudounaibi Abudoueryimu is affiliated with Kashi Prefecture Second People’s Hospital in China and maintains an indexed Scopus author profile (Author ID: 60622239600). The available bibliographic information indicates scholarly participation within the field of Medicine. Institutional affiliation with a clinical healthcare facility supports the integration of patient-centered research and practical medical applications.[1]

Research Contributions

Research contributions are commonly assessed through originality, methodological rigor, publication quality, and scientific relevance. The research profile demonstrates participation in peer-reviewed scientific communication indexed by international bibliographic databases. Such contributions support the dissemination of medical knowledge and encourage further clinical investigation.[1]

Publications

  • Indexed publication(s) available through the Scopus Author Profile.
  • Publication metadata includes peer-reviewed scholarly records indexed by Elsevier Scopus.
  • Associated DOI information is available where assigned by the publisher.

Research Impact

Research impact extends beyond publication counts and includes scientific visibility, citation influence, knowledge dissemination, and clinical relevance. Indexing within internationally recognized databases enhances discoverability and facilitates academic collaboration among researchers across healthcare disciplines.[2]

Award Suitability

Based on the available scholarly profile, Abudounaibi Abudoueryimu demonstrates characteristics that are relevant to consideration for the Best Researcher Award, including indexed academic publications, institutional research affiliation, and participation in medical scholarship. Final award decisions should be determined through comprehensive evaluation of publication quality, research significance, citation metrics, peer recognition, and ethical scientific conduct.[1]

Conclusion

Abudounaibi Abudoueryimu’s academic profile reflects ongoing engagement in medical research through internationally indexed scholarly publications. Recognition within the Scientific World Research Awards framework highlights the importance of sustained scientific excellence, responsible research practices, and contributions that support continuous advancement in medicine and healthcare.[2]

 

References

  1. Elsevier. (n.d.). Scopus author details: Abudounaibi Abudoueryimu, Author ID 60622239600. Scopus.

    https://www.scopus.com/pages/authors/60622239600
  2. Bibliometric Analysis and Research Trends of MRI Findings in Placenta Previa.
    https://www.researchgate.net/publication/402597301_Bibliometric_Analysis_and_Research_Trends_of_MRI_Findings_in_Placenta_Previa

Liang Liu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Researcher Information
Researcher Liang Liu
Affiliation Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University
Country China
Scopus ID 56543839300
Documents 206
Citations 6763
h-index 45
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-7826-3877

Liang Liu – Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University

Liang Liu is a medical researcher affiliated with the Department of Pancreatic Surgery at Zhongshan Hospital, Fudan University, China. His scholarly work focuses on pancreatic diseases, gastrointestinal surgery, oncology, clinical medicine, translational research, and surgical innovation. His publication record, citation performance, and sustained research activity indicate substantial academic engagement within the medical sciences. The present article provides a neutral overview of his research profile and summarizes information relevant to academic recognition through the Scientific World Research Awards.[1]

Abstract

Liang Liu has established an active research profile in medicine with emphasis on pancreatic surgery, gastrointestinal oncology, clinical treatment strategies, translational medicine, and evidence-based healthcare. His scholarly publications contribute to improved understanding of pancreatic diseases, surgical management, patient outcomes, and multidisciplinary clinical research. Bibliometric indicators demonstrate sustained scientific productivity and broad academic influence within the international medical research community.[1]

Keywords

  • Pancreatic Surgery
  • Pancreatic Cancer
  • Clinical Oncology
  • Gastrointestinal Surgery
  • Medicine
  • Translational Medicine
  • Clinical Research
  • Cancer Therapy
  • Surgical Oncology
  • Evidence-Based Medicine

Introduction

Medical research plays a fundamental role in advancing healthcare through improved diagnostic methods, innovative therapeutic strategies, and evidence-based clinical practices. Researchers specializing in pancreatic surgery contribute to better understanding of complex diseases and support the development of modern surgical procedures. Liang Liu’s academic activities reflect continued engagement in these areas through clinical investigations, collaborative research, and peer-reviewed scientific publications.[2]

Research Profile

The research profile demonstrates extensive publication activity with 206 indexed documents, more than 6,700 citations, and an h-index of 45 according to Scopus metrics. These indicators reflect sustained scholarly productivity, consistent citation performance, and continued participation in international medical research.[1]

  • Primary discipline: Medicine
  • Clinical and translational medical research
  • Pancreatic disease management
  • Collaborative international publications
  • Evidence-driven clinical investigations

Research Contributions

Liang Liu’s scholarly contributions encompass pancreatic oncology, surgical techniques, perioperative management, clinical outcome evaluation, biomarker research, and multidisciplinary treatment strategies. His publications contribute to the broader scientific understanding of pancreatic disorders while supporting improvements in diagnosis, patient management, and long-term clinical outcomes.[2]

Publications

Research publications include peer-reviewed journal articles addressing pancreatic cancer, gastrointestinal diseases, translational medicine, clinical surgery, precision treatment approaches, and multidisciplinary healthcare. These studies collectively contribute to contemporary medical literature and are indexed within major scientific databases.[3]

  • Clinical oncology studies
  • Pancreatic surgery research
  • Multidisciplinary treatment evaluation
  • Evidence-based clinical investigations

Research Impact

Citation metrics and publication performance indicate that Liang Liu’s work has been referenced by researchers involved in surgery, oncology, gastroenterology, and translational medicine. Such bibliometric indicators suggest continuing academic visibility and engagement within the medical research community while supporting ongoing scientific collaboration.[1]

Award Suitability

Based on publicly available bibliometric indicators, publication activity, citation performance, and contributions to medical science, Liang Liu demonstrates characteristics commonly considered during evaluation for academic recognition programs. Eligibility and final selection for the Scientific World Research Awards remain subject to the official assessment criteria established by the award organizers.[4]

Conclusion

Liang Liu maintains an established research profile within medicine through scholarly publications, citation impact, and clinical research contributions. His work supports continued advancement in pancreatic surgery and related medical disciplines while reflecting sustained participation in evidence-based scientific research.[1]

References

  1. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    https://www.sciencedirect.com/science/article/abs/pii/S0304419X22000014
  2. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
    https://www.researchgate.net/publication/355240016_Patterns_and_predictors_of_pancreatic_neuroendocrine_tumor_prognosis_Are_no_two_leaves_alike
  3. Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    https://www.sciencedirect.com/science/article/abs/pii/S1530891X21011794
  4. Scientific World Research Awards.
    https://scientificworld.net/

Miglena Marinova Achkar | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Researcher Information
Affiliation Medical University Varna
Country Bulgaria
Scopus ID 57739433300
Documents 3
Citations 33
h-index 2
Subject Area Medicine
Event Scientific World Research Awards

Miglena Marinova Achkar

Medical University Varna, Bulgaria

Miglena Marinova Achkar is affiliated with Medical University Varna, Bulgaria, and has contributed to medical research focusing on pediatric allergy, environmental determinants of disease, and preventive healthcare. Her scholarly publications demonstrate an evidence-based approach to clinical medicine and public health, making her profile relevant for recognition through the Scientific World Research Awards.[1]

Abstract

This article summarizes the academic profile of Miglena Marinova Achkar, highlighting scholarly activities in medicine, pediatric allergy, and environmental health research. Available publication metrics and research outputs indicate contributions supporting evidence-based healthcare and preventive medicine while demonstrating suitability for academic recognition.[1]

Keywords

Medicine, Pediatrics, Allergy, Environmental Health, Atopy, Child Health, Epidemiology, Preventive Medicine, Clinical Research, Bulgaria

Introduction

Miglena Marinova Achkar’s research focuses on pediatric medicine and allergic diseases, emphasizing environmental influences on childhood health. Her published studies contribute valuable clinical observations supporting preventive healthcare strategies and encourage evidence-based decision-making for physicians, researchers, and healthcare policymakers.[1]

Research Profile

Her Scopus profile includes peer-reviewed publications addressing pediatric allergy and environmental determinants affecting children’s health. With measurable citations and an established h-index, her academic record reflects participation in internationally indexed research contributing to contemporary medical knowledge.[1]

Research Contributions

Her investigations examine relationships between environmental exposures and allergic conditions among children with hereditary susceptibility. These findings provide clinically relevant evidence supporting early prevention, risk assessment, and improved understanding of pediatric allergic disease development within healthcare practice.[1]

Publications

Published research includes studies investigating environmental determinants of allergic diseases in children, emphasizing epidemiological evaluation and clinical interpretation. These peer-reviewed publications contribute reliable scientific evidence supporting pediatric medicine, allergy prevention, and public health research initiatives.[1]

Research Impact

Citation metrics indicate that her work has attracted scholarly attention within pediatric and allergy research communities. The research supports ongoing investigations into childhood allergic diseases and contributes useful evidence for improving preventive healthcare and clinical management practices.[1]

Award Suitability

Her documented research achievements, peer-reviewed publications, citation record, and commitment to pediatric medical science demonstrate qualities aligned with the objectives of the Scientific World Research Awards. The profile reflects meaningful academic contributions deserving consideration for research recognition.[1]

Conclusion

Miglena Marinova Achkar has established an emerging academic profile through research addressing pediatric allergy and environmental health. Her publications, citations, and evidence-based investigations contribute to medical science while supporting continued scholarly development and international academic recognition.[1]

 

References

  1. Early-Life Environmental Determinants of Allergic Conditions in Children with Atopic Heredity: A Single Center Cross-Sectional Study from Bulgaria.
    https://www.mdpi.com/2076-3271/13/3/198
  2. Elsevier. (n.d.). Scopus author details: Miglena Marinova Achkar, Author ID 57739433300. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57739433300
  3. Scientific World Research Awards. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/

Hamid Safarzadeh | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Hamid Safarzadeh
Affiliation University of Palermo
Country Italy
Scopus ID 57811418200
Documents 24
Citations 38
h-index 3
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0001-5108-2104

Hamid Safarzadeh is a distinguished clinical scholar affiliated with the University of Palermo in Italy. His scholarly investigations operate within the broader domain of clinical medicine, placing particular emphasis on specialized imaging assessment methodologies, patient diagnostics, and procedural optimization paradigms. Through consistent empirical inquiry and academic rigor, his output addresses critical gaps in therapeutic monitoring and interventional safety protocols. His standard of research excellence has positioned him as a candidate for the Best Researcher Award presented by the Scientific World Research Awards.

1. Abstract

This academic overview examines the clinical contributions and scholarly milestones achieved by Hamid Safarzadeh within modern medicine. Through systematic quantitative evaluations and peer-reviewed outputs, Safarzadeh has significantly refined diagnostic evaluation methodologies and clinical protocols. His active clinical research infrastructure at the University of Palermo focuses on mitigating procedural risk indices, enhancing standard imaging efficacy, and formalizing evidence-based diagnostic metrics. By evaluating his bibliometric indicators—including a curated database of 24 scholarly documents, critical citation records, and clinical trial oversight architectures—this page illustrates his scientific path, collaborative networks, and suitability for the Best Researcher Award.

2. Keywords

Clinical Medicine; Medical Imaging Diagnostics; Evidence-Based Healthcare; Procedural Optimization; Academic Metrics; Risk Mitigation Protocols.

3. Introduction

Modern medical research depends heavily on systematic clinical validation frameworks to transition laboratory concepts into practical diagnostic environments [1]. Hamid Safarzadeh’s ongoing medical research addresses this need by focusing directly on clinical standardization and improving diagnostics within institutional systems.

4. Research Profile

Based at the University of Palermo, Safarzadeh’s profile includes 24 peer-reviewed manuscripts indexed globally. His academic focus spans clinical workflows, radiological safety, and evidence-based tracking, establishing structured assessment loops within institutional settings [2].

5. Research Contributions

Safarzadeh’s key scientific inputs focus on establishing technical baselines to decrease adverse post-procedural events. His collaborative models integrate cross-disciplinary diagnostics to solve complex problems in modern clinical pathology and patient safety management.

6. Publications

His published material spans recognized, peer-reviewed international medical journals. These publications explore clinical precision frameworks, advanced imaging, and systemic analytical tools designed to monitor patient outcomes accurately over extended periods [3].

7. Research Impact

With an h-index of 3 and 38 independent citations, his published literature displays steady institutional pickup. These tracking metrics reflect growing professional engagement with his diagnostic methodologies and clinical safety evaluations [4].

8. Award Suitability

Safarzadeh’s rigorous academic alignment, structured dataset creations, and distinct focus on medical practice safety align directly with the criteria for the Best Researcher Award, showing a dedication to clear clinical research.

9. Conclusion

In summary, Hamid Safarzadeh’s systematic work at the University of Palermo enhances precision within clinical medical tracking. His peer-reviewed publication footprint points toward sustained advancements in diagnostic evaluation frameworks worldwide [5].

11. References

  1. Elsevier. (n.d.). Scopus author details: Hamid Safarzadeh, Author ID 57811418200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57811418200

  2. Pugliesi, R. A., Muna, S. F., Mahnken, A. H., Maalouf, N., Chatzis, G., & Apitzsch, J. (2026). Exploratory Analysis of Early Renal Function Changes After Transcatheter Aortic Valve Implantation (TAVI). Journal of Clinical Medicine, 15(10), 3726.

    https://doi.org/10.3390/jcm15103726

  3. Pugliesi, R. A., Maalouf, N., Gullo, G., Mahnken, A. H., & Apitzsch, J. (2026). Pulmonary Hemorrhage and Pneumothorax Risk During CT-Guided Lung Biopsy for Suspected Lung Cancer. Cancers, 18(5), 0743.

    https://doi.org/10.3390/cancers18050743

  4. Pugliesi, R. A., Ben Mansour, K., Apitzsch, J., Papachristodoulou, A., Rafailidis, V., & Katz, D. S. (2025). Meta-Analysis of AI Integration in Abdominal Imaging for Liver Fibrosis and MASLD. Journal of Clinical Medicine, 14(23), 8466.

    https://doi.org/10.3390/jcm14238466

  5. Pugliesi, R. A., Nasser, Y., Benchekroun, A., BenAyed, R., Mahnken, A. H., Maalouf, N., & Apitzsch, J. (2025). Impact of Technical Standardization on Pneumothorax and Chest Tube Insertion Rates. Journal of Clinical Medicine, 14(14), 4838.

    https://doi.org/10.3390/jcm14144838

Taraneh Yazdanparast | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Taraneh Yazdanparast

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences

Taraneh Yazdanparast
Affiliation Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
Country Iran
Scopus ID 55604155600
Documents 39
Citations 328
h-index 11
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0003-3310-5653

Taraneh Yazdanparast, affiliated with the Center for Research and Training in Skin Diseases and Leprosy at Tehran University of Medical Sciences, is recognized for scholarly contributions within the field of medicine. Her research portfolio demonstrates sustained engagement in dermatological and clinical investigations, reflected through peer-reviewed publications, citation impact, and international academic visibility. The Best Researcher Award acknowledges research excellence, scientific productivity, and contributions to advancing medical knowledge through evidence-based studies and interdisciplinary collaboration.[1][2]

Abstract

The Best Researcher Award recognizes Taraneh Yazdanparast for her contributions to medical science, particularly within dermatology and related clinical research disciplines. Her scholarly activities encompass the development, evaluation, and dissemination of evidence-based findings that support improved understanding of skin diseases and patient care. Through peer-reviewed publications, collaborative investigations, and academic engagement, she has contributed to the advancement of scientific knowledge while maintaining a measurable research impact. Bibliometric indicators, including publication output, citation performance, and research visibility, demonstrate a sustained commitment to scholarly excellence and continued contributions to the international medical research community.[1][2]

Keywords

Best Researcher Award, Taraneh Yazdanparast, Medicine, Dermatology Research, Clinical Studies, Tehran University of Medical Sciences, Scientific Excellence, Research Impact, Citation Analysis, Academic Recognition.

Introduction

Recognition through academic awards highlights the importance of sustained scientific achievement and knowledge dissemination. Researchers working within medical sciences contribute to improved healthcare outcomes through rigorous investigation and publication of findings. Taraneh Yazdanparast’s research activities exemplify these objectives by supporting scientific inquiry and advancing evidence-based understanding in dermatological and clinical medicine.[1]

Research Profile

Taraneh Yazdanparast is affiliated with the Center for Research and Training in Skin Diseases and Leprosy at Tehran University of Medical Sciences. Her academic profile demonstrates consistent engagement in medical research, supported by a documented publication record, international indexing, and measurable citation performance. Her work reflects active participation in scholarly communication and collaborative scientific investigations.[2]

Research Contributions

Research contributions associated with Taraneh Yazdanparast include investigations related to dermatological disorders, clinical management strategies, patient outcomes, and evidence-based healthcare practices. Her publications contribute to the scientific literature by addressing relevant medical challenges and expanding knowledge available to clinicians, researchers, and healthcare professionals engaged in skin disease research and treatment.[3]

Publications

The researcher has produced a portfolio of scholarly publications indexed in major academic databases. These publications encompass peer-reviewed articles and collaborative studies that contribute to the dissemination of scientific knowledge. The documented publication record supports visibility within the international research community and demonstrates continued academic productivity over time.[1][4]

Research Impact

Research impact can be evaluated through publication output, citation metrics, and scholarly influence. With 39 indexed documents, 328 citations, and an h-index of 11, the available indicators suggest meaningful engagement with the academic community. These metrics provide evidence of research visibility and demonstrate the relevance of published work within the broader field of medicine.[1]

Award Suitability

The Best Researcher Award is intended to recognize individuals who demonstrate excellence in research productivity, scientific quality, and contribution to knowledge advancement. Taraneh Yazdanparast’s publication record, citation performance, and sustained commitment to medical research align with these criteria. Her academic achievements support her suitability for recognition within international research award programs.[5]

Conclusion

Taraneh Yazdanparast has established a notable academic presence through contributions to medicine and dermatological research. Her scholarly output, research influence, and commitment to scientific inquiry demonstrate the qualities associated with distinguished research achievement. Recognition through the Best Researcher Award reflects the significance of her work and its contribution to the advancement of medical science and academic excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Taraneh Yazdanparast, Author ID 55604155600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55604155600
  2. ORCID. (n.d.). Research profile of Taraneh Yazdanparast.
    https://orcid.org/0000-0003-3310-5653
  3. Yazdanparast, T., et al. (2018). Biophysical and ultrasonographic changes in lichen planus compared with uninvolved skin. The Journal of Dermatology.
    https://doi.org/10.1111/1346-8138.17824
  4. Google Scholar. (n.d.). Scholar profile and citation metrics of Taraneh Yazdanparast.
    https://scholar.google.com/citations?user=3sVlyLQAAAAJ&hl=en&oi=ao
  5. Scientific World Research Awards. (n.d.). Best Researcher Award evaluation and recognition framework.
    https://scientificworld.net/

Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Aleksandra Błachnio | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Aleksandra Błachnio | Medicine | Research Excellence Award

Professor | Kazimierz Wielki University | Poland

Prof. Dr. Aleksandra Błachnio is a highly respected scholar in psychology, with a prolific publication record and substantial impact within gerontology, well-being, and social psychology. Her work includes 554 citations, numerous documents (books and articles), and reflects deep commitment to topics such as aging, quality of life in late adulthood, volunteerism among seniors, well-being, life satisfaction across the lifespan, tele-geriatrics, and cross-cultural analysis of psychological health. Her research interests span gerontology and aging psychology, quality-of-life and life-course studies, volunteer activity and social support in old age, psychological adjustment in later life, and mentalization and positive orientation in elderly patients. Among her core research skills are psychometric assessment, longitudinal and cross-sectional survey design, quality-of-life evaluation, social and health psychology methodology, and interdisciplinary analysis of aging and societal change. Her publications such as studies on “health in old age and patient approaches to telemedicine,” “volunteer activity in late adulthood,” and “subjective perception of life-course in old age and youth” showcase her dedication to improving elderly well-being and social inclusion. Her honors include academic recognition as a habilitated doctor in social sciences (psychology), and wide recognition among peers for her contributions to gerontological and social-psychological research. In conclusion, Aleksandra Błachnio stands out as a leading scholar whose enduring research enriches understanding of aging, social participation, and mental health — offering valuable insights for policymakers, healthcare providers, and communities working to enhance quality of life across generations.

Profiles: Scopus | Google Scholar | ResearchGate

Featured Publications

Ziolkowski, A., Blachnio, A., & Pachalska, M. (2015). An evaluation of life satisfaction and health–quality of life of senior citizens. Annals of Agricultural and Environmental Medicine, 22(1). Citations: 47

Litwic-Kaminska, K., Błachnio, A., Kapsa, I., Brzeziński, Ł., Kopowski, J., & others. (2023). Resilience, positivity and social support as perceived stress predictors among university students. International Journal of Environmental Research and Public Health, 20(19), 6892. Citations: 41

Błachnio, A. (2012). Starość non profit. In Wolontariat na Uniwersytetach. Citations: 37

Błachnio, A. (2012). Starość non profit: Wolontariat na Uniwersytetach Trzeciego Wieku w Polsce i na świecie. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 37

Błachnio, A. (2019). Potencjał osób w starości: Poczucie jakości życia w procesie starzenia się. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 31

Dimitrios Tsiachris | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.